Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autologous stem cell transplantation leads to a change in proinflammatory plasma cytokine profile of patients with juvenile dermatomyositis correlating with disease activity.
Bellutti Enders F, Delemarre EM, Kuemmerle-Deschner J, van der Torre P, Wulffraat NM, Prakken BP, van Royen-Kerkhof A, van Wijk F. Bellutti Enders F, et al. Among authors: van der torre p, van wijk f, van royen kerkhof a. Ann Rheum Dis. 2015 Jan;74(1):315-7. doi: 10.1136/annrheumdis-2014-206287. Epub 2014 Sep 30. Ann Rheum Dis. 2015. PMID: 25269830 No abstract available.
Regarding "Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea".
Mertens JS, de Jong EMGJ, Pandit A, Seyger MMB, Hoppenreijs EPAH, Thurlings RM, Vonk MC, Wienke J, van Wijk F, van Royen-Kerkhof A, Marut W, Radstake TRD. Mertens JS, et al. Among authors: van wijk f, van royen kerkhof a. J Invest Dermatol. 2018 May;138(5):1212-1215. doi: 10.1016/j.jid.2017.11.032. Epub 2017 Dec 12. J Invest Dermatol. 2018. PMID: 29246801 Free article. No abstract available.
Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome.
van den Hoogen LL, van Roon JAG, Mertens JS, Wienke J, Lopes AP, de Jager W, Rossato M, Pandit A, Wichers CGK, van Wijk F, Fritsch-Stork RDE, Radstake TRDJ. van den Hoogen LL, et al. Among authors: van roon jag, van wijk f. Ann Rheum Dis. 2018 Dec;77(12):1810-1814. doi: 10.1136/annrheumdis-2018-213497. Epub 2018 Sep 5. Ann Rheum Dis. 2018. PMID: 30185417
Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation.
Wienke J, Bellutti Enders F, Lim J, Mertens JS, van den Hoogen LL, Wijngaarde CA, Yeo JG, Meyer A, Otten HG, Fritsch-Stork RDE, Kamphuis SSM, Hoppenreijs EPAH, Armbrust W, van den Berg JM, Hissink Muller PCE, Tekstra J, Hoogendijk JE, Deakin CT, de Jager W, van Roon JAG, van der Pol WL, Nistala K, Pilkington C, de Visser M, Arkachaisri T, Radstake TRDJ, van der Kooi AJ, Nierkens S, Wedderburn LR, van Royen-Kerkhof A, van Wijk F. Wienke J, et al. Among authors: van roon jag, van der pol wl, van der kooi aj, van den berg jm, van den hoogen ll, van wijk f, van royen kerkhof a. Arthritis Rheumatol. 2019 Aug;71(8):1377-1390. doi: 10.1002/art.40881. Epub 2019 Mar 12. Arthritis Rheumatol. 2019. PMID: 30861625 Free PMC article.
The identification of CCL18 as biomarker of disease activity in localized scleroderma.
Mertens JS, de Jong EMGJ, van den Hoogen LL, Wienke J, Thurlings RM, Seyger MMB, Hoppenreijs EPAH, Wijngaarde CA, van Vlijmen-Willems IMJJ, van den Bogaard E, Giovannone B, van Wijk F, van Royen-Kerkhof A, Marut W, Radstake TRD. Mertens JS, et al. Among authors: van den bogaard e, van den hoogen ll, van vlijmen willems imjj, van wijk f, van royen kerkhof a. J Autoimmun. 2019 Jul;101:86-93. doi: 10.1016/j.jaut.2019.04.008. Epub 2019 Apr 18. J Autoimmun. 2019. PMID: 31006523
148 results